A carregar...
Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells
Sorafenib is currently the standard chemotherapy drug for treatment of advanced hepatocellular carcinoma (HCC). But its efficacy requires improvement, it is imperative to seek therapeutic strategies that combine sorafenib with other anticancer agents. In this study we investigated the synergistic an...
Na minha lista:
| Publicado no: | Acta Pharmacol Sin |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Singapore
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7921114/ https://ncbi.nlm.nih.gov/pubmed/32300243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-020-0395-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|